Description

Name: BPC-157 (Body Protection Compound-157) / TB-500 (Thymosin Beta-4 Fragment)

Sequence: BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr

Molecular Formula: BPC-157: C₆₂H₉₈N₁₆O₂₂ TB-500: C₂₂₁H₃₆₅N₆₉O₆₁

Molecular Weight: BPC-157: ≈ 1419.54 g/mol TB-500: ≈ 4963.49 g/mol

CAS Registry Number: BPC-157: 137525-51-0 TB-500: 77591-33-4

BPC-157/TB-500 – COMPREHENSIVE RESEARCH PEPTIDE COMBINATION FOR CELLULAR, ANGIOGENIC, AND CYTOSKELETAL STUDIES

Scientific Overview of BPC-157/TB-500

BPC-157 and TB-500 are synthetic research peptides often evaluated together in in-vitro and in-vivo studies investigating cellular growth, migration, and cytoskeletal regulation.

BPC-157 is a pentadecapeptide originally derived from a protective protein found in gastric juice, commonly studied for its interactions with angiogenic, growth factor, and nitric oxide pathways (Seiwerth et al., 2018; Chang et al., 2014; Sikiric et al., 2016).

TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein associated with actin-binding and cytoskeletal organization, investigated for its influence on cell motility and tissue remodeling mechanisms (Malinda et al., 1999; Smart et al., 2007).

Together, this peptide combination is frequently used in research models to explore molecular pathways related to cellular structure, repair signaling, and angiogenic response.

*This peptide is intended solely for laboratory research use. It is not approved for human consumption or therapeutic application.

COA for this item

BT1010V1125